Fr. 201.30

Pharmacogenomics in Drug Discovery and Development

English · Hardback

Shipping usually within 3 to 5 weeks (title will be specially ordered)

Description

Read more










Pharmacogenomics refers to the study of the influence of genes in an individual's response to drugs. This field draws from two fields, namely, pharmacology and genomics. It aims at developing safe and effective medications that can be prescribed based on an individual's genetic makeup. Pharmacogenomics involves the use of genetics to reduce unfavorable drug responses, enhance drug therapies and increase drug efficacy. The use of pharmacogenomics in drug development is expected to eliminate the unpredictable response of drug treatments that occurs due to genetic polymorphisms, which affect metabolism, tolerance and clearance. Pharmacogenomics can potentially be used to create tailored drugs for treating a variety of health issues such as Alzheimer's disease, asthma, cardiovascular disease, and cancer. This book aims to shed light on the role of pharmacogenomics in drug discovery and development. It covers in detail some existent theories and innovative concepts revolving around this domain. Those in search of information to further their knowledge will be greatly assisted by this book.

Product details

Assisted by Karoline Hodge (Editor)
Publisher Murphy & Moore Publishing
 
Languages English
Product format Hardback
Released 26.09.2023
 
EAN 9781639877812
ISBN 978-1-63987-781-2
No. of pages 251
Dimensions 216 mm x 279 mm x 16 mm
Weight 875 g
Subject Natural sciences, medicine, IT, technology > Medicine > Pharmacy

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.